Enhancing the QUAlity and Transparency Of health Research
Use your browser's Back button to return to your search results
|Reporting guideline provided for?
(i.e. exactly what the authors state in the paper)
|The establishment, analysis and presentation of data from biologics registers in rheumatology|
|Full bibliographic reference||Dixon WG, Carmona L, Finckh A, Hetland ML, Kvien TK, Landewe R, Listing J, Nicola PJ, Tarp U, Zink A, Askling J. EULAR points to consider when establishing, analysing and reporting safety data of biologics registers in rheumatology. Ann Rheum Dis. 2010;69(9):1596-1602.|
|Study design||Observational studies|
|Applies to the whole report or to individual sections of the report?||Whole report|
|Record last updated on||January 27, 2015|
Some reporting guidelines are also available in languages other than English. Find out more in our Translations section.